Klotho gene expression decreases in peripheral blood mononuclear cells (PBMCs) of patients with relapsing-remitting

Masoumeh Karami1, Farzad Mehrabi2, Abdolamir Allameh3

  • 1Department of Biochemistry, School of Medicine, AJA University of Medical Sciences, Tehran, Iran.

Abstract

Insights

Klotho gene expression is significantly reduced in peripheral blood mononuclear cells (PBMCs) of multiple sclerosis (MS) patients. This finding suggests Klotho may play a role in MS pathogenesis and warrants further investigation.

Area of Science:

  • Neuroimmunology
  • Molecular Biology
  • Genetics

Background:

  • Klotho, a protein with anti-aging and anti-inflammatory properties, is implicated in the etiology and pathogenesis of multiple sclerosis (MS).
  • Klotho's function and gene expression are modulated by inflammatory pathways, suggesting a link to MS.
  • Investigating Klotho gene expression in MS patients is crucial for understanding its role.

Purpose of the Study:

  • To investigate the gene expression of Klotho in peripheral blood mononuclear cells (PBMCs) of patients diagnosed with multiple sclerosis (MS).

Main Methods:

  • Quantitative Real-Time PCR was employed to measure Klotho mRNA levels.
  • PBMCs were isolated from blood samples of 30 relapsing-remitting MS (RRMS) patients and 30 age/sex-matched healthy controls.

Main Results:

  • Klotho gene expression in PBMCs of RRMS patients was approximately 2.5-fold lower compared to healthy individuals (P=0.0006).

Conclusions:

  • This study provides the first evidence of a potential role for Klotho in the PBMCs of multiple sclerosis patients.
  • The observed downregulation of Klotho in MS patients suggests its involvement in the disease process.